NLRP6 and colitis: Further in vivo evidence emphasized a protective role for NLRP6 in intestinal inflammation and tumorigenesis as Nlrp6−/− mice showed high susceptibility to DSS-induced colitis and AOM–DSS-induced CRC (216–218).